Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiji Nishino

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Expert Opinion on Investigational Drugs|November 1, 2007
The hypocretin/orexin receptor: therapeutic prospective in sleep disordersSeiji Nishino
Sleep Medicine|May 2, 2007
Clinical and neurobiological aspects of narcolepsySeiji Nishino
Sleep|November 26, 2009
Rebound hypersomnolence, stimulant abuse, and DAT-mediated dopamine releaseSeiji Nishino
Neuropeptides|March 23, 2007
The hypothalamic peptidergic system, hypocretin/orexin and vigilance controlSeiji Nishino
The Journal of Clinical Psychiatry|December 19, 2007
Narcolepsy: pathophysiology and pharmacologySeiji Nishino
Biological Psychiatry|July 23, 2003
The hypocretin/orexin system in health and diseaseSeiji Nishino
Handbook of Clinical Neurology|November 9, 2010
Hypothalamus, hypocretins/orexin, and vigilance controlSeiji Nishino
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 21, 2022
Comparison of Solriamfetol and Modafinil on Arousal and Anxiety-Related Behaviors in Narcoleptic MiceNoriaki Sakai, Seiji Nishino
Sleep|February 16, 2006
Emerging therapies in narcolepsy-cataplexyEmmanuel Mignot, Seiji Nishino
Sleep Medicine Clinics|August 6, 2017
Pharmacologic Management of Excessive Daytime SleepinessShinichi Takenoshita, Seiji Nishino
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Expert Opinion on Investigational Drugs|November 1, 2007
The hypocretin/orexin receptor: therapeutic prospective in sleep disordersSeiji Nishino
Sleep Medicine|May 2, 2007
Clinical and neurobiological aspects of narcolepsySeiji Nishino
Sleep|November 26, 2009
Rebound hypersomnolence, stimulant abuse, and DAT-mediated dopamine releaseSeiji Nishino
Neuropeptides|March 23, 2007
The hypothalamic peptidergic system, hypocretin/orexin and vigilance controlSeiji Nishino
The Journal of Clinical Psychiatry|December 19, 2007
Narcolepsy: pathophysiology and pharmacologySeiji Nishino
Biological Psychiatry|July 23, 2003
The hypocretin/orexin system in health and diseaseSeiji Nishino
Handbook of Clinical Neurology|November 9, 2010
Hypothalamus, hypocretins/orexin, and vigilance controlSeiji Nishino
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 21, 2022
Comparison of Solriamfetol and Modafinil on Arousal and Anxiety-Related Behaviors in Narcoleptic MiceNoriaki Sakai, Seiji Nishino
Sleep|February 16, 2006
Emerging therapies in narcolepsy-cataplexyEmmanuel Mignot, Seiji Nishino
Sleep Medicine Clinics|August 6, 2017
Pharmacologic Management of Excessive Daytime SleepinessShinichi Takenoshita, Seiji Nishino
Pageof 14